Skip To Main Content
Asbjørn Høegholm on Muck Rack

Asbjørn Høegholm

As seen in: Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Asbjørn

Contact Asbjørn, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Re-biopsy after first line treatment in advanced NSCLC can reveal changes in PD-L1 expression

|
By Uffe Bodtger, Malene Støchkel Frank, Asbjørn Høegholm, Inger Merete Stamp
| Lung Cancer Verified
Highlights • Re-biopsy in advanced NSCLC is feasible with a low rate of complications. • Changes in PD-L1 TPS can be observed in 33% of patients with advanced NSCLC at progression. • Change of PD-L1 TPS was significantly more likely (p = 0.005) patients treated with chemotherapy than in patients treated with immunotherapy.
Open in Who Shared Issue with article?
See all 1 articles